O	O	O	0	17	Immunosuppression	Immunosuppression	B-NP	NN	O	5	NMOD	O
O	O	O	18	20	by	by	B-PP	IN	O	1	NMOD	O
O	O	O	21	36	glucocorticoids	glucocorticoid	B-NP	NNS	O	2	PMOD	O
O	O	O	36	37	:	:	O	:	O	1	P	O
O	O	O	38	48	inhibition	inhibition	B-NP	NN	O	0	ROOT	O
O	O	O	49	51	of	of	B-PP	IN	O	5	NMOD	O
T2	B-Entity	B-Entity	52	54	NF	NF	B-NP	NN	B-protein	11	NMOD	B-protein
T2	I-Entity	I-Entity	54	55	-	-	B-NP	HYPH	I-protein	11	NMOD	I-protein
T2	I-Entity	I-Entity	55	60	kappa	kappa	I-NP	NN	I-protein	11	NMOD	I-protein
T2	I-Entity	I-Entity	61	62	B	B	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	O	63	71	activity	activity	I-NP	NN	O	6	PMOD	O
O	O	O	72	79	through	through	B-PP	IN	O	5	NMOD	O
O	O	O	80	89	induction	induction	B-NP	NN	O	12	PMOD	O
O	O	O	90	92	of	of	B-PP	IN	O	13	NMOD	O
O	O	O	93	94	I	I	B-NP	NN	B-protein	17	NMOD	B-protein
O	O	O	95	100	kappa	kappa	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	O	101	102	B	B	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	O	103	112	synthesis	synthesis	I-NP	NN	O	14	PMOD	O
O	O	O	113	114	[	[	O	(	O	20	VMOD	O
O	O	O	114	117	see	see	B-VP	VB	O	5	NMOD	O
O	O	O	118	126	comments	comment	B-NP	NNS	O	20	OBJ	O
O	O	O	126	127	]	]	O	)	O	20	VMOD	O

O	O	O	129	144	Glucocorticoids	Glucocorticoid	B-NP	NNS	O	2	SUB	O
O	O	O	145	148	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	149	154	among	among	B-PP	IN	O	2	PRD	O
O	O	O	155	158	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	159	163	most	most	I-NP	RBS	O	6	AMOD	O
O	O	O	164	170	potent	potent	I-NP	JJ	O	12	NMOD	O
O	O	O	171	175	anti	anti	I-NP	AFX	O	12	NMOD	O
O	O	O	175	176	-	-	I-NP	HYPH	O	12	P	O
O	O	O	176	188	inflammatory	inflammatory	I-NP	JJ	O	11	AMOD	O
O	O	O	189	192	and	and	I-NP	CC	O	11	AMOD	O
O	O	O	193	210	immunosuppressive	immunosuppressive	I-NP	JJ	O	12	NMOD	O
O	O	O	211	217	agents	agent	I-NP	NNS	O	3	PMOD	O
O	O	O	217	218	.	.	O	.	O	2	P	O

O	O	O	219	223	They	They	B-NP	PRP	O	2	SUB	O
O	O	O	224	231	inhibit	inhibit	B-VP	VBP	O	26	VMOD	O
O	O	O	232	241	synthesis	synthesis	B-NP	NN	O	2	OBJ	O
O	O	O	242	244	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	245	251	almost	almost	B-NP	RB	O	7	AMOD	O
O	O	O	252	255	all	all	I-NP	DT	O	7	AMOD	O
O	O	O	256	261	known	know	I-NP	VBN	O	8	NMOD	O
O	O	O	262	271	cytokines	cytokine	I-NP	NNS	B-protein	4	PMOD	B-protein
O	O	O	272	275	and	and	B-PP	CC	O	4	PMOD	O
O	O	O	276	278	of	of	B-PP	IN	O	4	PMOD	O
O	O	O	279	286	several	several	B-NP	JJ	O	10	PMOD	O
O	O	O	287	291	cell	cell	I-NP	NN	B-protein	14	NMOD	B-protein
O	O	O	292	299	surface	surface	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	O	300	309	molecules	molecule	I-NP	NNS	I-protein	11	NMOD	I-protein
O	O	O	310	318	required	require	B-VP	VBN	O	11	NMOD	O
O	O	O	319	322	for	for	B-PP	IN	O	15	VMOD	O
O	O	O	323	329	immune	immune	B-NP	JJ	O	18	NMOD	O
O	O	O	330	338	function	function	I-NP	NN	O	16	PMOD	O
O	O	O	338	339	,	,	O	,	O	26	P	O
O	O	O	340	343	but	but	O	CC	O	26	VMOD	O
O	O	O	344	347	the	the	B-NP	DT	O	22	NMOD	O
O	O	O	348	357	mechanism	mechanism	I-NP	NN	O	26	SUB	O
O	O	O	358	368	underlying	underlie	B-VP	VBG	O	22	NMOD	O
O	O	O	369	373	this	this	B-NP	DT	O	25	NMOD	O
O	O	O	374	382	activity	activity	I-NP	NN	O	23	OBJ	O
O	O	O	383	386	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	O	387	391	been	be	I-VP	VBN	O	26	VC	O
O	O	O	392	399	unclear	unclear	B-ADJP	JJ	O	27	PRD	O
O	O	O	399	400	.	.	O	.	O	26	P	O

O	O	O	401	405	Here	Here	B-ADVP	RB	O	3	VMOD	O
O	O	O	406	408	it	it	B-NP	PRP	O	3	SUB	O
O	O	O	409	411	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	412	417	shown	show	I-VP	VBN	O	3	VC	O
O	O	O	418	422	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	O	423	438	glucocorticoids	glucocorticoid	B-NP	NNS	O	7	SUB	O
O	O	O	439	442	are	be	B-VP	VBP	O	5	SBAR	O
O	O	O	443	449	potent	potent	B-NP	JJ	O	9	NMOD	O
O	O	O	450	460	inhibitors	inhibitor	I-NP	NNS	O	7	PRD	O
O	O	O	461	463	of	of	B-PP	IN	O	9	NMOD	O
T3	B-Entity	B-Entity	464	471	nuclear	nuclear	B-NP	JJ	B-protein	14	NMOD	B-protein
T3	I-Entity	I-Entity	472	478	factor	factor	I-NP	NN	I-protein	14	NMOD	I-protein
T3	I-Entity	I-Entity	479	484	kappa	kappa	I-NP	NN	I-protein	14	NMOD	I-protein
T3	I-Entity	I-Entity	485	486	B	B	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	O	487	488	(	(	O	(	O	20	DEP	O
T4	B-Entity	B-Entity	488	490	NF	NF	B-NP	NN	B-protein	19	NMOD	B-protein
T4	I-Entity	I-Entity	490	491	-	-	B-NP	HYPH	I-protein	19	NMOD	I-protein
T4	I-Entity	I-Entity	491	496	kappa	kappa	I-NP	NN	I-protein	19	NMOD	I-protein
T4	I-Entity	I-Entity	497	498	B	B	I-NP	NN	I-protein	20	DEP	I-protein
O	O	O	498	499	)	)	O	)	O	14	NMOD	O
O	O	O	500	510	activation	activation	B-NP	NN	O	10	PMOD	O
O	O	O	511	513	in	in	B-PP	IN	O	21	NMOD	O
O	O	O	514	518	mice	mouse	B-NP	NNS	O	26	NMOD	O
O	O	O	519	522	and	and	O	CC	O	26	NMOD	O
O	O	O	523	531	cultured	culture	B-NP	VBN	B-cell_line	26	NMOD	B-cell_line
O	O	O	532	537	cells	cell	I-NP	NNS	I-cell_line	22	PMOD	I-cell_line
O	O	O	537	538	.	.	O	.	O	3	P	O

O	O	O	539	543	This	This	B-NP	DT	O	2	NMOD	O
O	O	O	544	554	inhibition	inhibition	I-NP	NN	O	3	SUB	O
O	O	O	555	557	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	558	566	mediated	mediate	I-VP	VBN	O	3	VC	O
O	O	O	567	569	by	by	B-PP	IN	O	4	VMOD	O
O	O	O	570	579	induction	induction	B-NP	NN	O	5	PMOD	O
O	O	O	580	582	of	of	B-PP	IN	O	6	NMOD	O
O	O	O	583	586	the	the	B-NP	DT	O	14	NMOD	O
T1	B-Protein	B-Protein	587	588	I	I	I-NP	NN	B-protein	14	NMOD	B-protein
T1	I-Protein	I-Protein	589	594	kappa	kappa	I-NP	NN	I-protein	14	NMOD	I-protein
T1	I-Protein	I-Protein	595	596	B	B	I-NP	NN	I-protein	14	NMOD	I-protein
T1	I-Protein	I-Protein	597	602	alpha	alpha	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	O	603	613	inhibitory	inhibitory	I-NP	JJ	I-protein	14	NMOD	I-protein
O	O	O	614	621	protein	protein	I-NP	NN	I-protein	7	PMOD	I-protein
O	O	O	621	622	,	,	O	,	O	14	P	O
O	O	O	623	628	which	which	B-NP	WDT	O	14	NMOD	O
O	O	O	629	634	traps	trap	B-VP	VBZ	O	16	SBAR	O
O	O	O	635	644	activated	activate	B-NP	VBN	O	22	NMOD	O
T5	B-Entity	B-Entity	645	647	NF	NF	I-NP	NN	B-protein	22	NMOD	B-protein
T5	I-Entity	I-Entity	647	648	-	-	B-NP	HYPH	I-protein	22	NMOD	I-protein
T5	I-Entity	I-Entity	648	653	kappa	kappa	I-NP	NN	I-protein	22	NMOD	I-protein
T5	I-Entity	I-Entity	654	655	B	B	I-NP	NN	I-protein	17	OBJ	I-protein
O	O	O	656	658	in	in	B-PP	IN	O	17	VMOD	O
T6	B-Entity	B-Entity	659	667	inactive	inactive	B-NP	JJ	B-protein	26	NMOD	B-protein
T6	I-Entity	I-Entity	668	679	cytoplasmic	cytoplasmic	I-NP	JJ	I-protein	26	NMOD	I-protein
T6	I-Entity	I-Entity	680	689	complexes	complex	I-NP	NNS	I-protein	23	PMOD	I-protein
O	O	O	689	690	.	.	O	.	O	3	P	O

O	O	O	691	698	Because	Because	B-SBAR	IN	O	23	VMOD	O
T7	B-Entity	B-Entity	699	701	NF	NF	B-NP	NN	B-protein	5	NMOD	B-protein
T7	I-Entity	I-Entity	701	702	-	-	B-NP	HYPH	I-protein	5	NMOD	I-protein
T7	I-Entity	I-Entity	702	707	kappa	kappa	I-NP	NN	I-protein	5	NMOD	I-protein
T7	I-Entity	I-Entity	708	709	B	B	I-NP	NN	I-protein	6	SUB	I-protein
O	O	O	710	719	activates	activate	B-VP	VBZ	O	1	SBAR	O
O	O	O	720	724	many	many	B-NP	JJ	O	6	OBJ	O
T8	B-Entity	B-Entity	725	741	immunoregulatory	immunoregulatory	I-NP	JJ	B-DNA	9	NMOD	B-DNA
T8	I-Entity	I-Entity	742	747	genes	gene	I-NP	NNS	I-DNA	7	NMOD	I-DNA
O	O	O	748	750	in	in	B-PP	IN	O	6	VMOD	O
O	O	O	751	759	response	response	B-NP	NN	O	10	PMOD	O
O	O	O	760	762	to	to	B-PP	TO	O	11	NMOD	O
O	O	O	763	766	pro	pro	B-NP	AFX	B-cell_type	16	NMOD	B-cell_type
O	O	O	766	767	-	-	I-NP	HYPH	O	16	NMOD	O
O	O	O	767	779	inflammatory	inflammatory	I-NP	JJ	O	16	NMOD	O
O	O	O	780	787	stimuli	stimulus	I-NP	NNS	O	12	PMOD	O
O	O	O	787	788	,	,	O	,	O	23	P	O
O	O	O	789	792	the	the	B-NP	DT	O	19	NMOD	O
O	O	O	793	803	inhibition	inhibition	I-NP	NN	O	23	SUB	O
O	O	O	804	806	of	of	B-PP	IN	O	19	NMOD	O
O	O	O	807	810	its	its	B-NP	PRP$	O	22	NMOD	O
O	O	O	811	819	activity	activity	I-NP	NN	O	20	PMOD	O
O	O	O	820	823	can	can	B-VP	MD	O	0	ROOT	O
O	O	O	824	826	be	be	I-VP	VB	O	23	VC	O
O	O	O	827	828	a	a	B-NP	DT	O	27	NMOD	O
O	O	O	829	834	major	major	I-NP	JJ	O	27	NMOD	O
O	O	O	835	844	component	component	I-NP	NN	O	24	PRD	O
O	O	O	845	847	of	of	B-PP	IN	O	27	NMOD	O
O	O	O	848	851	the	the	B-NP	DT	O	33	NMOD	O
O	O	O	852	856	anti	anti	I-NP	AFX	O	33	NMOD	O
O	O	O	856	857	-	-	I-NP	HYPH	O	33	NMOD	O
O	O	O	857	869	inflammatory	inflammatory	I-NP	JJ	O	33	NMOD	O
O	O	O	870	878	activity	activity	I-NP	NN	O	28	PMOD	O
O	O	O	879	881	of	of	B-PP	IN	O	33	NMOD	O
O	O	O	882	897	glucocorticoids	glucocorticoid	B-NP	NNS	O	34	PMOD	O
O	O	O	897	898	.	.	O	.	O	23	P	O
